Effect of Atorvastatin on MMP-9 and Tissue Factor Induced by Oxldl in Human Monocytes-Derived Macrophages

TONG Guo-xin,WANG Ning-fu,CHEN Peng,ZHANG Xing-wei,XU Jian,ZHU Yong-liang
DOI: https://doi.org/10.3969/j.issn.1001-6325.2007.02.013
2007-01-01
Abstract:Objective To investigate the effect of atorvastatin-a HMG-CoA reductase inhibitor on the expression and activity of matrix metalloproteinase-9(MMP-9) and tissue factor(TF) on human monocytes induced by Oxidized LDL(oxLDL).Methods Human monocytes-derived macrophages were incubated with oxLDL in the presence or absence of different concentration atorvastatin.At the end of incubation,MMP-9 expression and its activity was assessed by ELISA and zymography analysis respectively.TF expression and its procoagulant activity was assessed by ELISA and a clotting assay respectively.Results The results showed that atorvastatin inhibited human monocytes-derived macrophages proliferation which can be eliminated by adding 100 μmol/L mevalonate.0.1 μmol/L and 0.5 μmol/L atorvastatin can inhibit MMP-9 expression(1.32±0.06 vs 2.57±0.06 μg/L,P0.05;1.25±0.04 vs 2.57±0.06 μg/L,P0.01,respectively)and its activity of human monocytes-derived macrophages significantly,and inhibit TF expression(3.34±0.66 vs 5.78±0.86 μg/L,P0.05;2.20±0.60 vs 5.78±0.86 μg/L,P0.01,respectively) and its procoagulant activity in a concentration-dependant manner.Conclusion Atorvastatin inhibit the proliferation of human monocytes-derived macrophages,and also inhibit MMP-9 and TF expressionsand their activities induced by oxLDL,which can lead to collagen degradation and blood clotting.
What problem does this paper attempt to address?